Overview
INJ and FGRS rarely move in perfect sync. Today’s print ($5.13/$1,882.43) and 24h leaders (Injective) help frame which side currently carries relative strength.
Quick winners
Full comparison
| Metric | INJ | FGRS |
|---|---|---|
| Price | $5.13 | $1,882.43 |
| Market Cap | $490.41M | $170.00M |
| FDV | — | — |
| Volume 24h | $2.59M | $24.60 |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 99.00 | 175.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +5.97% | +3.64% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | INJ | FGRS |
|---|---|---|
| 1H | — | — |
| 24H | +3.91% | -1.50% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | INJ | FGRS |
|---|---|---|
| RSI | 49.29 | 49.02 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 0.29 | 67.35 |
| ADX | 12.19 | 21.33 |
| Support | 4.91 | 1,827.82 |
| Resistance | 5.47 | 1,960.30 |
| Trend | neutral | bearish |
| Momentum | — | 59.00 |
| Signal | neutral | neutral |
Automatic technical analysis
Automated technical notes for this pair highlight neutral conditions on INJ and bearish on FGRS. Volatility differences can amplify short-term gaps.
Fundamentals
| Metric | INJ | FGRS |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | 0.00 | — |
| Github activity | 118.00 | — |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
Injective
FGRS
Pros and cons
Pros of Injective
- Composite PEPS readings for Injective can surface clearer module agreement during trend phases.
- Injective has an established coin page footprint on PEPS for continuous monitoring.
- INJ often anchors narratives that attract sustained media and analyst coverage.
Cons of Injective
- When dominance narratives fade, Injective can lag hotter rotation names.
- Large-cap status for Injective can mean slower percentage upside versus high-beta alternatives.
- Crowded positioning around INJ sometimes amplifies squeeze or flush risk.
Pros of FGRS
- Active volume bursts on FGRS sometimes precede sharper tactical moves.
- Diversifying versus Injective with FGRS can change portfolio factor exposure.
- FGRS can offer higher relative beta when market attention rotates toward its niche.
Cons of FGRS
- Smaller book depth versus large caps can increase slippage for FGRS.
- Higher volatility on FGRS cuts both ways and demands stricter risk limits.
Which looks stronger right now?
Across winners above, no single coin dominates every column. Prefer scenarios: trend continuation favors the side with aligned momentum; mean-reversion favors the side stretched on RSI.
AI summary
PEPS synthesizes module output into a readable pair brief. Headline stats put Injective at $5.13 and FGRS at $1,882.43. Relative performance over 24h (Injective) is a short window. Pair it with 30d/1y rows before inferring regime change. Return to related comparisons and individual coin intelligence pages to validate whether the relative story still holds after fresh prints.
FAQ
Which is better, Injective or FGRS?
“Better” depends on horizon and risk. Injective leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, INJ or FGRS?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both Injective and FGRS.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. Injective currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.